MALAT1 functions as a competing endogenous RNA to mediate Rac1 expression by sequestering miR-101b in liver fibrosis

Reference

• Gong L, Han Y, Chen L, Liu F, Hao P, Sheng J, Li XH, Yu DM, Gong QM, Tian F, et al. Comparison of next-generation sequencing and clone-based sequencing in analysis of hepatitis B virus reverse transcriptase quasispecies heterogeneity. J Clin Microbiol 2013; 51:4087-94; PMID:24088859; http://dx.doi.org/10.1128/JCM.01723-13
   PubMed Web of Science ®Google Scholar
• Kisseleva T, Brenner DA. Inactivation of myofibroblasts during regression of liver fibrosis. Cell Cycle 2013; 12:381-2; PMID:23324345; http://dx.doi.org/10.4161/cc.23549
   PubMed Web of Science ®Google Scholar
• Yang G, Lu X, Yuan L. LncRNA: a link between RNA and cancer. Biochim Biophys Acta 2014; 1839:1097-109; PMID:25159663; http://dx.doi.org/10.1016/j.bbagrm.2014.08.012
   PubMed Web of Science ®Google Scholar
• Zheng J, Wu C, Lin Z, Guo Y, Shi L, Dong P, Lu Z, Gao S, Liao Y, Chen B, et al. Curcumin up-regulates phosphatase and tensin homologue deleted on chromosome 10 through microRNA-mediated control of DNA methylation–a novel mechanism suppressing liver fibrosis. FEBS J 2014; 281:88-103; PMID:24138392; http://dx.doi.org/10.1111/febs.12574
   PubMed Web of Science ®Google Scholar
• Jimenez Calvente C, Sehgal A, Popov Y, Kim YO, Zevallos V, Sahin U, Diken M, Schuppan D. Specific hepatic delivery of procollagen alpha1(I) siRNA in lipid-like nanoparticles resolves liver fibrosis. Hepatology 2015; 62(4):1285-97; PMID:26096209
   PubMed Web of Science ®Google Scholar
• Yu F, Guo Y, Chen B, Dong P, Zheng J. MicroRNA-17-5p activates hepatic stellate cells through targeting of Smad7. Lab Invest 2015; 95:781-9; PMID:25915722; http://dx.doi.org/10.1038/labinvest.2015.58
   PubMed Web of Science ®Google Scholar
• Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y. MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway. J Pathol 2014; 234:46-59; PMID:24817606; http://dx.doi.org/10.1002/path.4373
   PubMed Web of Science ®Google Scholar
• Bae JS, Kim JH, Pasaje CF, Cheong HS, Lee TH, Koh IS, Lee HS, Kim YJ, Shin HD. Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases. Dig Liver Dis 2012; 44:849-54; PMID:22658643; http://dx.doi.org/10.1016/j.dld.2012.04.021
   PubMedGoogle Scholar
• Xie Y, Yao Q, Butt AM, Guo J, Tian Z, Bao X, Li H, Meng Q, Lu J. Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Cancer Biol Ther 2014; 15:1248-55; PMID:24971953; http://dx.doi.org/10.4161/cbt.29688
   PubMed Web of Science ®Google Scholar
• Li S, Wang Q, Qiang Q, Shan H, Shi M, Chen B, Zhao S, Yuan L. Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor. J Cancer Res Clin Oncol 2015; 141(11):1909-20.
   PubMed Web of Science ®Google Scholar
• Shen L, Chen L, Wang Y, Jiang X, Xia H, Zhuang Z. Long noncoding RNA MALAT1 promotes brain metastasis by inducing epithelial-mesenchymal transition in lung cancer. J Neurooncol 2015; 121:101-8; PMID:25217850; http://dx.doi.org/10.1007/s11060-014-1613-0
   PubMed Web of Science ®Google Scholar
• Vassallo I, Zinn P, Lai M, Rajakannu P, Hamou MF, Hegi ME. WIF1 re-expression in glioblastoma inhibits migration through attenuation of non-canonical WNT signaling by downregulating the lncRNA MALAT1. Oncogene 2015; PMID:25772239.
   PubMed Web of Science ®Google Scholar
• Hu L, Wu Y, Tan D, Meng H, Wang K, Bai Y, Yang K. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J Exp Clin Cancer Res 2015; 34:7; PMID:25613496; http://dx.doi.org/10.1186/s13046-015-0123-z
   PubMed Web of Science ®Google Scholar
• Hirata H, Hinoda Y, Shahryari V, Deng G, Nakajima K, Tabatabai ZL, Ishii N, Dahiya R. Long Noncoding RNA MALAT1 Promotes Aggressive Renal Cell Carcinoma through Ezh2 and Interacts with miR-205. Cancer Res 2015; 75:1322-31; PMID:25600645; http://dx.doi.org/10.1158/0008-5472.CAN-14-2931
   PubMed Web of Science ®Google Scholar
• Yang MH, Hu ZY, Xu C, Xie LY, Wang XY, Chen SY, Li ZG. MALAT1 promotes colorectal cancer cell proliferation/migration/invasion via PRKA kinase anchor protein 9. Biochim Biophys Acta 2015; 1852:166-74; PMID:25446987; http://dx.doi.org/10.1016/j.bbadis.2014.11.013
   PubMed Web of Science ®Google Scholar
• Ji Q, Zhang L, Liu X, Zhou L, Wang W, Han Z, Sui H, Tang Y, Wang Y, Liu N, et al. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br J Cancer 2014; 111:736-48; PMID:25025966; http://dx.doi.org/10.1038/bjc.2014.383
   PubMed Web of Science ®Google Scholar
• Dong Y, Liang G, Yuan B, Yang C, Gao R, Zhou X. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Tumour Biol 2015; 36:1477-86; PMID:25431257; http://dx.doi.org/10.1007/s13277-014-2631-4
   PubMed Web of Science ®Google Scholar
• Li B, Chen P, Qu J, Shi L, Zhuang W, Fu J, Li J, Zhang X, Sun Y. Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma. J Biol Chem 2014; 289:29365-75; PMID:25187517; http://dx.doi.org/10.1074/jbc.M114.572693
   PubMed Web of Science ®Google Scholar
• Wang J, Su L, Chen X, Li P, Cai Q, Yu B, Liu B, Wu W, Zhu Z. MALAT1 promotes cell proliferation in gastric cancer by recruiting SF2/ASF. Biomed Pharmacother 2014; 68:557-64; PMID:24857172; http://dx.doi.org/10.1016/j.biopha.2014.04.007
   PubMed Web of Science ®Google Scholar
• Wu XS, Wang XA, Wu WG, Hu YP, Li ML, Ding Q, Weng H, Shu YJ, Liu TY, Jiang L, et al. MALAT1 promotes the proliferation and metastasis of gallbladder cancer cells by activating the ERK/MAPK pathway. Cancer Biol Ther 2014; 15:806-14; PMID:24658096; http://dx.doi.org/10.4161/cbt.28584
   PubMed Web of Science ®Google Scholar
• Pang EJ, Yang R, Fu XB, Liu YF. Overexpression of long non-coding RNA MALAT1 is correlated with clinical progression and unfavorable prognosis in pancreatic cancer. Tumour Biol 2015; 36:2403-7; PMID:25481511; http://dx.doi.org/10.1007/s13277-014-2850-8
   PubMed Web of Science ®Google Scholar
• Zhang HM, Yang FQ, Chen SJ, Che J, Zheng JH. Upregulation of long non-coding RNA MALAT1 correlates with tumor progression and poor prognosis in clear cell renal cell carcinoma. Tumour Biol 2015; 36:2947-55; PMID:25480417; http://dx.doi.org/10.1007/s13277-014-2925-6
   PubMed Web of Science ®Google Scholar
• Zheng HT, Shi DB, Wang YW, Li XX, Xu Y, Tripathi P, Gu WL, Cai GX, Cai SJ. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int J Clin Exp Pathol 2014; 7:3174-81; PMID:25031737
   PubMed Web of Science ®Google Scholar
• Cho SF, Chang YC, Chang CS, Lin SF, Liu YC, Hsiao HH, Chang JG, Liu TC. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer 2014; 14:809; PMID:25369863; http://dx.doi.org/10.1186/1471-2407-14-809
   PubMed Web of Science ®Google Scholar
• Liu JH, Chen G, Dang YW, Li CJ, Luo DZ. Expression and prognostic significance of lncRNA MALAT1 in pancreatic cancer tissues. Asian Pac J Cancer Prev 2014; 15:2971-7; PMID:24815433; http://dx.doi.org/10.7314/APJCP.2014.15.7.2971
   PubMed Web of Science ®Google Scholar
• Weber DG, Johnen G, Casjens S, Bryk O, Pesch B, Jockel KH, Kollmeier J, Bruning T. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res Notes 2013; 6:518; PMID:24313945; http://dx.doi.org/10.1186/1756-0500-6-518
   PubMedGoogle Scholar
• Wang X, Li M, Wang Z, Han S, Tang X, Ge Y, Zhou L, Zhou C, Yuan Q, Yang M. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells. J Biol Chem 2015; 290:3925-35; PMID:25538231; http://dx.doi.org/10.1074/jbc.M114.596866
   PubMed Web of Science ®Google Scholar
• Tay Y, Rinn J, Pandolfi PP. The multilayered complexity of ceRNA crosstalk and competition. Nature 2014; 505:344-52; PMID:24429633; http://dx.doi.org/10.1038/nature12986
   PubMed Web of Science ®Google Scholar
• Cesana M, Cacchiarelli D, Legnini I, Santini T, Sthandier O, Chinappi M, Tramontano A, Bozzoni I. A long noncoding RNA controls muscle differentiation by functioning as a competing endogenous RNA. Cell 2011; 147:358-69; PMID:22000014; http://dx.doi.org/10.1016/j.cell.2011.09.028
   PubMed Web of Science ®Google Scholar
• Miranda KC, Huynh T, Tay Y, Ang YS, Tam WL, Thomson AM, Lim B, Rigoutsos I. A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes. Cell 2006; 126:1203-17; PMID:16990141; http://dx.doi.org/10.1016/j.cell.2006.07.031
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhu Z, Watabe K, Zhang X, Bai C, Xu M, Wu F, Mo YY. Negative regulation of lncRNA GAS5 by miR-21. Cell Death Differ 2013; 20:1558-68; PMID:23933812; http://dx.doi.org/10.1038/cdd.2013.110
   PubMed Web of Science ®Google Scholar
• Choi SS, Sicklick JK, Ma Q, Yang L, Huang J, Qi Y, Chen W, Li YX, Goldschmidt-Clermont PJ, Diehl AM. Sustained activation of Rac1 in hepatic stellate cells promotes liver injury and fibrosis in mice. Hepatology 2006; 44:1267-77; PMID:17058265; http://dx.doi.org/10.1002/hep.21375
   PubMed Web of Science ®Google Scholar
• Choi SS, Witek RP, Yang L, Omenetti A, Syn WK, Moylan CA, Jung Y, Karaca GF, Teaberry VS, Pereira TA, et al. Activation of Rac1 promotes hedgehog-mediated acquisition of the myofibroblastic phenotype in rat and human hepatic stellate cells. Hepatology 2010; 52:278-90; PMID:20578145; http://dx.doi.org/10.1002/hep.23649
   PubMed Web of Science ®Google Scholar
• Okugawa Y, Toiyama Y, Hur K, Toden S, Saigusa S, Tanaka K, Inoue Y, Mohri Y, Kusunoki M, Boland CR, et al. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis 2014; 35:2731-9; PMID:25280565; http://dx.doi.org/10.1093/carcin/bgu200
   PubMed Web of Science ®Google Scholar
• Gutschner T, Hammerle M, Eissmann M, Hsu J, Kim Y, Hung G, Revenko A, Arun G, Stentrup M, Gross M, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res 2013; 73:1180-9; PMID:23243023; http://dx.doi.org/10.1158/0008-5472.CAN-12-2850
   PubMed Web of Science ®Google Scholar
• Karreth FA, Pandolfi PP. ceRNA cross-talk in cancer: when ce-bling rivalries go awry. Cancer Discov 2013; 3:1113-21; PMID:24072616; http://dx.doi.org/10.1158/2159-8290.CD-13-0202
   PubMed Web of Science ®Google Scholar
• Liu XH, Sun M, Nie FQ, Ge YB, Zhang EB, Yin DD, Kong R, Xia R, Lu KH, Li JH, et al. Lnc RNA HOTAIR functions as a competing endogenous RNA to regulate HER2 expression by sponging miR-331-3p in gastric cancer. Mol Cancer 2014; 13:92; PMID:24775712; http://dx.doi.org/10.1186/1476-4598-13-92
   PubMed Web of Science ®Google Scholar
• Song X, Cao G, Jing L, Lin S, Wang X, Zhang J, Wang M, Liu W, Lv C. Analysing the relationship between lncRNA and protein-coding gene and the role of lncRNA as ceRNA in pulmonary fibrosis. J Cell Mol Med 2014; 18:991-1003; PMID:24702795; http://dx.doi.org/10.1111/jcmm.12243
   PubMed Web of Science ®Google Scholar
• Han X, Yang F, Cao H, Liang Z. Malat1 regulates serum response factor through miR-133 as a competing endogenous RNA in myogenesis. FASEB J 2015; 29(7):3054-64.
   PubMed Web of Science ®Google Scholar
• Zhao X, Fu J, Xu A, Yu L, Zhu J, Dai R, Su B, Luo T, Li N, Qin W, et al. Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway. Cell Death Dis 2015; 6:e1751; PMID:25950481; http://dx.doi.org/10.1038/cddis.2015.120
   PubMed Web of Science ®Google Scholar
• Zhang F, Zhuge YZ, Li YJ, Gu JX. S-adenosylmethionine inhibits the activated phenotype of human hepatic stellate cells via Rac1 and matrix metalloproteinases. Int Immunopharmacol 2014; 19:193-200; PMID:24495518; http://dx.doi.org/10.1016/j.intimp.2014.01.021
   PubMed Web of Science ®Google Scholar
• Abshagen K, Brensel M, Genz B, Roth K, Thomas M, Fehring V, Schaeper U, Vollmar B. Foxf1 siRNA Delivery to Hepatic Stellate Cells by DBTC Lipoplex Formulations Ameliorates Fibrosis in Livers of Bile Duct Ligated Mice. Curr Gene Ther 2015; 15:215-27; PMID:25619889; http://dx.doi.org/10.2174/1566523215666150126114634
   PubMed Web of Science ®Google Scholar
• Chang W, Yang M, Song L, Shen K, Wang H, Gao X, Li M, Niu W, Qin X. Isolation and culture of hepatic stellate cells from mouse liver. Acta Biochim Biophys Sin (Shanghai) 2014; 46:291-8; PMID:24389643; http://dx.doi.org/10.1093/abbs/gmt143
   PubMed Web of Science ®Google Scholar
• Bai Y, Lu H, Zhang G, Wu C, Lin C, Liang Y, Chen B. Sedum sarmentosum Bunge extract exerts renal anti-fibrotic effects in vivo and in vitro. Life Sci 2014; 105:22-30; PMID:24747135; http://dx.doi.org/10.1016/j.lfs.2014.04.013
   PubMed Web of Science ®Google Scholar
• Yin LH, Zheng XQ, Li HY, Bi LX, Shi YF, Ye AF, Wu JB, Gao SM. Epigenetic deregulated miR-375 contributes to the constitutive activation of JAK2/STAT signaling in myeloproliferative neoplasm. Leuk Res 2015; 39:471-8; PMID:25666256; http://dx.doi.org/10.1016/j.leukres.2015.01.009
   PubMed Web of Science ®Google Scholar